Dr. Jensen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
Philadelphia, PA 19104Phone+1 215-590-2791
Education & Training
University of Pennsylvania Health System/Scheie Eye InstituteResidency, Ophthalmology, 2013 - 2016
Albert Einstein Medical CenterInternship, Transitional Year, 2012 - 2013
Perelman School of Medicine at the University of PennsylvaniaClass of 2012
Certifications & Licensure
PA State Medical License 2012 - 2024- American Board of Ophthalmology Ophthalmology
Clinical Trials
- Bevacizumab Treatment For Type 1 ROP Start of enrollment: 2022 May 18
Roles: Contact
Publications & Presentations
PubMed
- 32 citationsThrombocytopenia and retinopathy of prematurity.Anne K. Jensen, Gui-Shuang Ying, Jiayan Huang, Karen A. Karp, Graham E. Quinn
Journal of AAPOS. 2011-02-01 - 37 citationsPOSTNATAL SERUM INSULIN-LIKE GROWTH FACTOR I AND RETINOPATHY OF PREMATURITY.Anne K. Jensen, Gui-Shuang Ying, Jiayan Huang, Graham E. Quinn, Gil Binenbaum
Retina. 2017-05-01 - 28 citationsLongitudinal study of the association between thrombocytopenia and retinopathy of prematurity.Anne K. Jensen, Gui-Shuang Ying, Jiayan Huang, Graham E. Quinn, Gil Binenbaum
Journal of AAPOS. 2018-04-01
Press Mentions
Mike Dannheim, Co-Founder of Sensie – How Technology Can Help to Detect Stress and Offer Real Solutions to Eliminate ItSeptember 10th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
